RR

Ravi Rameshbhai Bambhroliya

Active Director Designated Partner DIN 10386003
DIN 10386003 First appointment Nov 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravi Rameshbhai Bambhroliya

Data last updated:

Ravi Rameshbhai Bambhroliya is a Designated Partner at Envacare Laboratory Llp (since 2023). The company operates in Healthcare.

DIN 10386003
Primary Designation Designated Partner
Industry Healthcare
First Appointment 08 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner08 Nov 20232023Active

Board colleagues of Ravi Rameshbhai Bambhroliya

NameDINCompanyDesignation
Ankita Rajeshbhai Babariya10386004Envacare Laboratory LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Envacare Laboratory Llp
Premium access

Shareholding and investment profile for Ravi Rameshbhai Bambhroliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Rameshbhai Bambhroliya

Ravi Rameshbhai Bambhroliya currently holds 1 directorship: Envacare Laboratory Llp (Designated Partner, since 08 Nov 2023).

Ravi Rameshbhai Bambhroliya was first appointed on 08 Nov 2023 as Designated Partner at Envacare Laboratory Llp.

The current boards of Ravi Rameshbhai Bambhroliya's companies include Ankita Rajeshbhai Babariya (Envacare Laboratory Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available